Full-Time

Bioinformatics Analyst

Quality Control/Variant Interpretation, Weekend shifts required

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Junior, Mid

Chicago, IL, USA

Hybrid position requiring in-office presence.

Category
Bioinformatics
Biology & Biotech
Required Skills
Bash
Python
SQL
Linux/Unix
Requirements
  • BS/BA in bioinformatics, computer science, molecular biology or genetics, or equivalent field of study
  • Programming skills: SQL, Bash, Python
  • Computational biology skills using Python
  • Experience working with next-generation sequencing data
  • Familiarity with Mac/Linux working environment
Responsibilities
  • Provide bioinformatics support for quality control and variant identification/interpretation, prior to clinical case sign-outs.
  • Evaluate sample and variant metrics to confirm data quality and integrity.
  • Provide timely notifications to laboratory and clinical personnel regarding potential sample irregularities.
  • Interpretation of single-nucleotide, insertion/deletion, and copy number variants, as well as variants predictive of protein fusion events, in both DNA and RNA data
  • Responsible for identifying and interpreting complex variant calls in low coverage, variable, and novel genomic regions, in addition to sequencing artifacts.
  • Use SQL and other scripting languages to retrieve relevant data from various bioinformatics databases.
  • Use Python to perform analyses on genomic data sets and maintain internal tools
  • Communicate findings in a clear and logical manner to help stakeholders make scientific and clinical decisions based on your interpretation of variant data
  • Produce high-quality, detailed documentation for analyses/projects
  • Track variant data through multiple systems, utilize code searches, and review documentation, to understand how a result was produced.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus's IPO and significant revenue generation indicate strong financial health and growth potential.
  • Collaborations with industry giants like SoftBank and United Therapeutics can lead to groundbreaking advancements and increased market share.
  • The company's focus on personalized therapy and AI-driven insights can significantly improve patient outcomes, making it a rewarding place to work for those passionate about healthcare innovation.

What critics are saying

  • The lawsuit from Guardant Health over patent infringement could result in financial and reputational damage.
  • Operating in a highly competitive market with peers like Foundation Medicine and Guardant Health requires continuous innovation to maintain a competitive edge.

What makes Tempus unique

  • Tempus leverages AI to provide actionable insights from medical data, setting it apart from competitors who may not integrate AI as deeply into their platforms.
  • Their focus on personalized therapy options and extensive cancer research, including a pan-cancer organoid platform and liquid biopsy assay, distinguishes them in the healthcare tech space.
  • Tempus's collaboration with major firms like SoftBank and United Therapeutics highlights its strong industry partnerships and credibility.

Help us improve and share your feedback! Did you find this helpful?